March 18, 2009 (FinancialWire) -- Kensey Nash Corp.'s (NASDAQ: KNSY) board has approved a stock repurchase that allows the company to repurchase up to a total of 600,000 of its issued and outstanding shares of common stock and has no scheduled expiration.

The company said it plans to finance the repurchases using its available cash.

Company CEO Joseph W. Kaufmann said, "Given our strong cash position and the recent trading price of our stock, we believe we will be able to implement this repurchase program while maintaining the required financial flexibility and strength to continue to grow our business."

Exton, Pennsylvania-based Kensey Nash is a medical device company that develops products and technologies in the fields of biomaterials and endovascular devices. The company had around 11,513,952 shares of common stock outstanding at February 28.

FinancialWire" ( http://www.financialwire.net ), an independent, proprietary news service of Investrend Communications, Inc., receives no compensation for its news or opinions. Further disclosure is at http://www.investrend.com/articles/secondlevel.asp?level=472 . To contact FinancialWire" write to inquiries@financialwire.net .

Free annual reports for companies mentioned in the news are accessible via http://investrend.ar.wilink.com/?level=279 .

Copyright(C)2009 by financialwire.net, Inc. All rights reserved.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.